Camblong Jurgi 4

What Happened
Jurgi Camblong, Executive Chairman and Director of SOPHiA GENETICS SA (SOPH), sold 17,685 shares in an open-market transaction on July 7, 2026 at $5.28 per share, generating proceeds of $93,327. This was a sale (not a purchase) and was executed to cover tax withholding obligations tied to vested restricted stock units.

Key Details

• Transaction date and price: July 7, 2026 — 17,685 shares sold at $5.28 each.
• Total proceeds: $93,327 (gross).
• Shares owned after transaction: Not disclosed in this filing.
• Footnote: The sale was to satisfy tax withholding from RSUs that vested on July 3, 2026 and was executed under a pre-established Rule 10b5-1(c) trading plan; trades were non-discretionary.
• Filing timeliness: Report filed July 8, 2026 (appears timely under Form 4 reporting rules).

Context
Sales to cover tax withholding on vested awards are common and generally considered routine rather than a directional vote on the company. The use of a pre-established 10b5-1 plan indicates the trade was automatic and not an ad hoc decision by the insider.